不透明
发表于 2025-3-23 10:59:04
http://reply.papertrans.cn/23/2212/221137/221137_11.png
抗生素
发表于 2025-3-23 14:58:00
http://reply.papertrans.cn/23/2212/221137/221137_12.png
北极熊
发表于 2025-3-23 19:08:57
https://doi.org/10.1007/978-981-10-3193-9related to basic functional and phenotypic analysis are described. This methodology can be applied to manufacture and assess chimeric antigen receptors for preclinical applications targeting a variety of molecules.
BROOK
发表于 2025-3-24 01:06:54
https://doi.org/10.1007/978-981-10-3193-9e immune cells, in particular T cells, to desired targets has the potential to lead to the creation of powerful cell-based therapies for a wide range of maladies. While conventional effector T cells (Teff) would be targeted towards cells to be eliminated, such as cancer cells, immunosuppressive regu
obstinate
发表于 2025-3-24 05:47:19
http://reply.papertrans.cn/23/2212/221137/221137_15.png
游行
发表于 2025-3-24 09:58:36
http://reply.papertrans.cn/23/2212/221137/221137_16.png
贵族
发表于 2025-3-24 12:09:32
https://doi.org/10.1007/978-981-10-3193-9n receptors (CARs) bear great promise for the treatment of multiple hematological malignancies and solid tumors. Current methods of producing large-scale CAR-NK cells mainly rely on mRNA transfection and viral vector transduction. However, mRNA CAR-NK cells were not stable in CAR expression while vi
NOCT
发表于 2025-3-24 18:02:34
https://doi.org/10.1007/978-3-031-37387-9cribe the development of a probiotic . Nissle 1917 platform encoding a synchronized lysis mechanism for the localized and sustained release of blocking nanobodies against immune checkpoint molecules like programmed cell death protein-ligand 1 and cytotoxic T lymphocyte–associated protein-4. Specific
Ascribe
发表于 2025-3-24 22:50:46
https://doi.org/10.1007/978-1-0716-3593-3CAR-T cells; NK-resistant lymphomas; cancer cells phagocytosis; lymphoblastic leukemia; SUPRA-CARs
Mnemonics
发表于 2025-3-25 01:05:52
http://reply.papertrans.cn/23/2212/221137/221137_20.png